Loading...
•
Jun 30, 2022
AVITA Medical Q2 2022 Earnings Report
Reported financial results for the second quarter ended June 30, 2022.
Key Takeaways
AVITA Medical reported a 23% increase in commercial revenue, reaching $8.2 million, while total revenue was $8.3 million. The gross profit margin improved by 3% to 83%.
Commercial revenue increased by 23% to $8.2 million compared to the corresponding period in the prior year.
Total revenue, including BARDA revenue, was $8.3 million compared to $10.3 million in the corresponding period in the prior year, which included $3.6 million in BARDA revenue.
Gross profit margin improved by 3% to 83% compared to the corresponding period in the prior year.
As of June 30, 2022, the Company had $91.1 million in cash, cash equivalents, and marketable securities, with no debt.
Forward Guidance
Commercial revenues in calendar year 2022 are projected to be approximately $30 million, excluding BARDA revenues, which represents a 20% increase year-over year. We project BARDA revenues of approximately $0.3 million in calendar year 2022, as compared to $7.9 million in calendar year 2021, since we completed delivery of RECELL units into the national stockpile in 2021.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...